Journal Home
Search for

Volume 4, Issue 4, Pages 267-273 (July 2010)


View previous. 7 of 15 View next.

Cardiac computed tomography for prediction of myocardial viability after reperfused acute myocardial infarction

Michael D. Shapiro, DOab, Ammar Sarwar, MDac, Koen Nieman, MDa, Khurram Nasir, MD, MPHa, Thomas J. Brady, MDa, Ricardo C. Cury, MDadCorresponding Author Informationemail address

Received 6 December 2009; accepted 6 April 2010. published online 21 April 2010.

Background

Perfusion defects (PDs) detected with cardiac magnetic resonance (CMR) imaging predict the functional recovery of myocardial function after acute myocardial infarction.

Objective

We evaluated the ability of cardiac computed tomography (CCT) to predict the recovery of regional left ventricular (LV) systolic function after ST elevation myocardial infarction (STEMI).

Methods

Seventeen patients (mean age, 60 ± 10 years) presenting with STEMI were prospectively studied. Each patient underwent CCT and CMR at baseline and after an average of 6 months. Areas of PD were quantified. Segmental LV systolic function was semiquantitatively assessed by CMR. An improvement at 6 months by ≥1 category in the regional wall motion score was considered LV recovery.

Results

Coronary artery revascularization was successfully performed with postprocedural TIMI 3 flow in 16 cases. On CCT assessment, 107 of 289 segments (37%) had some degree of PD. On follow-up, segments with <25% PD at baseline had no worsening of wall motion. In segments with >75% PD, 89% (9 of 11) showed akinesis or worsening of wall motion. The odds ratio for improvement in segmental wall motion with increasing PD category was 0.63 (95% CI, 0.42–0.97; P = 0.035). The degree of PD on CT predicted LV recovery at follow-up (P < 0.0001).

Conclusions

The transmural extent of myocardial infarction as detected and quantified with CCT predicts the recovery of regional systolic LV function after revascularization for acute STEMI.

a Cardiac MR PET CT Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

b Division of Cardiovascular Medicine, Oregon Health and Science University, Portland, OR, USA

c Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

d Cardiovascular MR and CT Program, Baptist Cardiac and Vascular Institute, 8900 N Kendall Drive, Miami, FL 33176, USA

Corresponding Author InformationCorresponding author.

 Conflict of interest: The authors report no conflicts of interest.

 Dr. Shapiro and Dr. Nasir have received support from NIH grant 1T32 HL076136-02.

PII: S1934-5925(10)00256-X

doi:10.1016/j.jcct.2010.04.004


View previous. 7 of 15 View next.